BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Covagen 

Y17 M22, Life Science ETH/Uni
Winterthurerstrasse 190
Zurich    CH-8057  Switzerland
Phone: 41-44-6356033 Fax: 41-44-6356896


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up





 Company News
Covagen Adds Baxter Ventures As Investor 2/19/2014 10:23:10 AM    More...
Covagen Locks In $47.2 Million Series B 12/10/2013 7:06:49 AM    More...
Covagen And Tanabe Research Laboratories U.S.A., Inc. Expand Strategic Research Collaboration For Development Of Bispecific FynomAbs 11/21/2013 6:37:21 AM    More...
Covagen Names Elias Papatheodorou Chief Business Officer 4/15/2013 6:25:34 AM    More...
Covagen Inks $146 Million Pact With Mitsubishi Tanabe Pharma Corporation 10/17/2012 7:20:48 AM    More...
Covagen Nominates Bispecific TNF/IL-17A Inhibitor as Drug Candidate to Enter Preclinical Development 12/12/2011 8:47:56 AM    More...
Sir Gregory Winter Joins Covagen's Scientific Advisory Board 9/20/2011 10:16:23 AM    More...
Covagen Nominates Franz Hefti as New Member of the Board of Directors 5/16/2011 11:14:54 AM    More...
Covagen Nominates Frank Walsh as Executive Chairman and Appoints Mathias Locher as Chief Development Officer 3/7/2011 10:37:01 AM    More...
Covagen Closes Series A Financing Round of CHF 6.3 Million 11/29/2010 7:13:47 AM    More...
12